top of page
Browse by category
Search


FDA grants De Novo approval for Distalmotion’s Dexter Surgical Robot for adult inguinal hernia repair
Distalmotion has been granted De Novo approval by the FDA to market the Dexter Surgical Robot for adult inguinal hernia repair. This...


Allurion submits 1st of three PMA modules to FDA
Allurion Technologies has submitted the first three modules of its premarket approval application (PMA) to the FDA for the Allurion...


FDA approves labelling update for VIVUS’ QSYMIA
The FDA has approved a labelling update for VIVUS’ QSYMIA (phentermine and topiramate extended-release capsules CIV) that has removed the...


Phenomix Sciences and InformedDNA enter partnership to advance genetics-driven obesity care
Phenomix Sciences has formed a new partnership to advance precision medicine in obesity with InformedDNA, that integrates Phenomix’s...


First patient enrolled in Endogenex’ ReCET clinical study
Endogenex has enrolled the first patient in the Re-Cellularization via Electroporation Therapy ( ReCET) clinical study, multi-centre,...


Implantica prepares Module 2 submission of PMA application to FDA for RefluxStop
Implantica has announces finalisation of the five-year CE mark study results as part of the upcoming Module 2 submission (of 3 modules)...


FDA grants De Novo marketing authorisation to GT Metabolic Solutions for its magnet compression anastomosis technology
GT Metabolic Solutions has announced its first-generation MagDI System for side-to-side duodeno-ileal anastomosis has been granted De...


Ten years in endobariatrics – the past, present and future
Bariatric News talked to Letizia Ceccarelli, Head of International Marketing – Endobariatrics at Boston Scientific about the changes she...


Olympus launches new Powerseal Sealer/Divider 5mm devices extending advanced bipolar surgical energy portfolio
Olympus has launched two new jaw designs in the Powerseal Sealer/Divider range of advanced bipolar surgical energy products: the...


Lilly releases Zepbound (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity
Eli Lilly and Company has announced Zepbound (tirzepatide) 2.5mg and 5mg single-dose vials are available for self-pay for patients with...
Browse by tag






bottom of page